Aralez Pharm Inc (ARLZQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,283 | 42,340 | 23,072 | -6,859 | -5,976 |
| Depreciation Amortization | 1,565 | 874 | 701 | -314 | -829 |
| Accounts receivable | -222 | 2,909 | -2,893 | 6,973 | -5,990 |
| Other Working Capital | -5,163 | 4,940 | -9,464 | -13,106 | -12,707 |
| Other Operating Activity | 2,953 | -271 | 6,355 | -1,831 | 11,994 |
| Operating Cash Flow | $-26,149 | $50,791 | $17,772 | $-15,137 | $-13,508 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -79 | -58 | -9 | -37 |
| Purchase Of Investment | -35,922 | -26,055 | -42,430 | -25,342 | -64,382 |
| Sale Of Investment | 24,395 | 49,171 | 32,341 | 37,614 | 66,219 |
| Investing Cash Flow | $-11,543 | $23,038 | $-10,146 | $12,263 | $1,801 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,306 | N/A | 328 | 33 | 167 |
| Other Financing Activity | -189 | -70 | 0 | 0 | 0 |
| Financing Cash Flow | $1,118 | $-70 | $328 | $33 | $167 |
| Beginning Cash Position | 104,991 | 31,232 | 23,278 | 26,119 | 37,660 |
| End Cash Position | 68,416 | 104,991 | 31,232 | 23,278 | 26,119 |
| Net Cash Flow | $-36,574 | $73,759 | $7,954 | $-2,841 | $-11,541 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,149 | 50,791 | 17,772 | -15,137 | -13,508 |
| Capital Expenditure | -16 | -79 | -58 | -9 | -37 |
| Free Cash Flow | -26,165 | 50,713 | 17,714 | -15,146 | -13,545 |